BeStock  
股票 › 生物科技 › EXEL

艾塞利斯制药 EXEL

美股市值排名 #1032生物科技
$69.57 +$0.86 (+1.25%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $69.57 0.00%
开盘$68.35
昨收$68.71
当日区间$68.01 – $70.32
成交量2.00M
市值$16.98B
市盈率(TTM)20.8
股息率–

基本面

最新报告季度:Q3, ended Sep 2026

营收$658.70M+10.2% YoY
营业利润$268.42M+4.7% YoY
净利润$218.10M+12.7% YoY
摊薄每股收益$0.85+23.2% YoY
自由现金流$269.89M-4.8% YoY
经营现金流$279.96M

营收,近8个季度

$566.8MDec '24$555.4MMar '25$568.3MJun '25$597.8MSep '25$598.7MDec '25$610.8MMar '26$628.7MJun '26$658.7MSep '26

净利润,近8个季度

$139.9MDec '24$159.6MMar '25$184.8MJun '25$193.6MSep '25$244.5MDec '25$210.5MMar '26$212.1MJun '26$218.1MSep '26

各季度摊薄每股收益

0.48Dec '240.55Mar '250.65Jun '250.69Sep '250.88Dec '250.79Mar '260.82Jun '260.85Sep '26

各季度自由现金流

$226.3MDec '24$189.0MMar '25$45.4MJun '25$283.6MSep '25$326.4MDec '25$249.8MMar '26$298.4MJun '26$269.9MSep '26

年度营收

$987.5MFY20$1.4BFY21$1.6BFY22$1.8BFY23$2.2BFY24$2.3BFY25

盈利能力与资产负债表

毛利率96.3%
营业利润率40.2%
净利率35.5%
净资产收益率44.3%
资产收益率33.2%
投入资本回报率38.5%
流动比率3.21
负债/资产比率27.0%
现金及投资$892.02M
总负债$162.20M
净现金(净负债)$729.82M
自由现金流/营收45.8%

营收构成

2026/Q2 季度

按业务线

  • CABOMETYX$570.65M 90.2%
  • License revenues$59.81M 9.5%
  • COMETRIQ$2.38M 0.4%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $658.70M $628.69M $610.81M $2.32B $598.66M
营业总收入 $658.70M $628.69M $610.81M $2.32B $598.66M
营业成本 $26.23M $20.66M $19.95M $83.70M $26.48M
毛利润 $632.46M $608.03M $590.86M $2.24B $572.18M
营业费用 $364.04M $359.62M $339.52M $1.34B $336.27M
销售及管理费用 $154.56M $147.63M $139.60M $518.73M $123.02M
-管理费用 $154.56M $147.63M $139.60M $518.73M $123.02M
研发费用 $209.48M $211.99M $199.92M $825.00M $213.25M
营业利润 $268.42M $248.41M $251.34M $892.70M $235.91M
非经营性利息净收入(支出) $14.32M $14.21M $16.13M $69.21M $17.43M
非经营性利息收入 $14.32M $14.21M $16.13M $69.21M $17.43M
其他收入(支出) $47,000.00 $54,000.00 $219,000.00 -$20.71M -$648,000.00
特殊收益(费用) $0.00 – – -$20.51M -$694,000.00
-减:重组及并购费用 $0.00 – – $20.51M $694,000.00
其他非经营性收入(支出) $47,000.00 $54,000.00 $219,000.00 -$198,000.00 $46,000.00
税前利润 $282.79M $262.68M $267.69M $941.21M $252.69M
税费 $64.69M $50.63M $57.22M $158.64M $8.16M
净利润 $218.10M $212.05M $210.47M $782.57M $244.53M
持续经营利润 $218.10M $212.05M $210.47M $782.57M $244.53M
归属母公司净利润 $218.10M $212.05M $210.47M $782.57M $244.53M
归属普通股股东净利润 $218.10M $212.05M $210.47M $782.57M $244.53M
基本每股收益 $0.88 $0.85 $0.81 $2.88 $0.92
摊薄每股收益 $0.85 $0.82 $0.79 $2.78 $0.88
-减:资本性资产减值 – – – $0.00 $0.00

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $2.51B $2.49B $2.59B $2.84B $2.84B
流动资产合计 $1.32B $1.25B $1.21B $1.44B $1.44B
现金及现金等价物与短期投资 $892.02M $839.39M $777.21M $1.06B $1.06B
-现金及现金等价物 $304.77M $281.45M $226.15M $482.49M $482.49M
-短期投资 $587.24M $557.94M $551.06M $576.60M $576.60M
应收款 $328.47M $322.21M $328.95M $286.92M $286.92M
-应收账款 $328.47M $322.21M $328.95M $286.92M $286.92M
存货 $29.87M $28.73M $26.61M $21.69M $21.69M
其他流动资产 $71.27M $60.50M $75.88M $75.60M $75.60M
非流动资产合计 $1.19B $1.24B $1.38B $1.40B $1.40B
固定资产净值 $324.86M $340.59M $378.40M $441.27M $441.27M
-固定资产原值 $324.86M $340.59M $378.40M $573.49M $573.49M
投资及预付款 $507.76M $544.93M $649.14M $603.60M $603.60M
商誉及其他无形资产 $63.68M $63.68M $63.68M $63.68M $63.68M
-商誉 $63.68M $63.68M $63.68M $63.68M $63.68M
一年以上递延资产 $295.56M $294.21M $293.73M $292.58M $292.58M
负债合计 $679.66M $650.47M $657.85M $683.10M $683.10M
流动负债合计 $411.88M $361.93M $370.98M $405.64M $405.64M
应付款 $30.83M $39.06M $24.15M $29.62M $29.62M
-应付账款 $30.83M $39.06M $24.15M $29.62M $29.62M
一年内应计费用 $94.94M $84.86M $93.13M $88.53M $88.53M
一年内预提费用 $70.77M $66.71M $65.89M $59.90M $59.90M
其他流动负债 $114.84M $102.66M $100.29M $125.38M $125.38M
非流动负债合计 $267.78M $288.55M $286.87M $277.46M $277.46M
长期债务及融资租赁负债 $162.20M $165.93M $169.54M $173.04M $173.04M
-长期融资租赁负债 $162.20M $165.93M $169.54M $173.04M $173.04M
其他非流动负债 $105.58M $122.62M $117.33M $104.42M $104.42M
股东权益合计 $1.83B $1.84B $1.94B $2.16B $2.16B
股东权益 $1.83B $1.84B $1.94B $2.16B $2.16B
股本 $245,000.00 $249,000.00 $254,000.00 $262,000.00 $262,000.00
-普通股 $245,000.00 $249,000.00 $254,000.00 $262,000.00 $262,000.00
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $2.10B $2.11B $2.15B $2.23B $2.23B
留存收益 -$258.80M -$262.53M -$215.79M -$76.83M -$76.83M
不影响留存收益的损益 -$6.59M -$2.01M -$415,000.00 $3.48M $3.48M
-可供出售证券 – $544.93M $649.14M – –
-累计折旧 – – – -$132.23M -$132.23M

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $279.96M $307.74M $251.85M $884.27M $333.52M
持续经营经营活动现金流净额 $279.96M $307.74M $251.85M $884.27M $333.52M
持续经营净利润 $218.10M $212.05M $210.47M $782.57M $244.53M
折旧、折耗与摊销 $6.94M $6.98M $6.95M $29.06M $6.95M
其他非现金项目 $5.63M $13.23M $6.00M $24.62M $8.67M
营运资金变动 $20.58M $42.92M -$620,000.00 -$191.20M -$72.96M
-应收款变动 -$6.25M $6.73M -$42.03M -$21.40M $22.81M
-存货变动 -$320,000.00 -$44,000.00 -$3.39M $12.23M $13.81M
-预付资产变动 -$4.81M $40.50M $58.65M -$133.77M -$97.03M
-应付账款及应计费用变动 $31.96M -$4.28M -$13.85M -$48.25M -$12.55M
投资活动现金流净额 -$6.71M $91.43M -$51.07M $350.44M $27.24M
持续经营投资活动现金流净额 -$6.71M $91.43M -$51.07M $350.44M $27.24M
固定资产购置及出售净额 -$2.49M -$6.82M -$1.51M -$8.43M -$1.16M
无形资产购置及出售净额 -$7.58M -$2.50M -$525,000.00 -$31.50M -$6.00M
投资购置及出售净额 $3.36M $100.75M -$49.04M $390.37M $34.40M
筹资活动现金流 -$249.92M -$343.88M -$457.11M -$969.59M -$254.57M
持续经营筹资活动现金流净额 -$249.92M -$343.88M -$457.11M -$969.59M -$254.57M
普通股发行净额 -$249.96M -$322.97M -$430.35M -$947.51M -$257.62M
股票期权行使所得 $3.40M $15.44M $7.47M $49.14M $7.88M
其他筹资费用净额 -$3.36M -$36.34M -$34.23M -$71.22M -$4.83M
期末现金余额 $304.77M $281.45M $226.15M $482.49M $482.49M
现金净变动 $23.33M $55.30M -$256.34M $265.11M $106.19M
期初现金余额 $281.45M $226.15M $482.49M $217.37M $376.30M
自由现金流 $269.89M $298.43M $249.81M $844.34M $326.36M
递延税款 – – – $126.24M –

讨论区

暂无评论——快来第一个聊聊 EXEL。

登录后参与讨论。

Scroll to Top